Clinical Trial

Sellar Masses: Clinical and Imaging Features With Correlation to Histopathology and Surgical Approach

Completed
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn about the clinical spectrum of sellar masses, aiming to understand the correlation between the imaging features and the future surgical approach and histopathology results. The main question it aims to answer is: Does being both LMIC and conflict country change the global data!? Participants were included during a period of 3 years in a governmental hospital TMGH.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-05.
Trial Details
NCT Number NCT07633860
Lead Sponsor Arab Board of Neurosurgery
Conditions Sellar Mass, Pituitray Tumor
Enrollment 49 participants
Start Date 2022-12-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-10